1. Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
   Maria Hernandez-Valladares et al, 2021, Cancers CrossRef
2. Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
   Sonia Abou Najem et al, 2019, Cells CrossRef
3. Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
   David S. Schrump, 2009, Clinical Cancer Research CrossRef
4. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
   Alexandra Neaga et al, 2021, Frontiers in Immunology CrossRef
5. Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
   Torsten Haferlach, 2008, Hematology CrossRef
6. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
   Øystein Bruserud et al, 2021, Pharmaceuticals CrossRef
7. Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
   Ida Sofie Grønningsæter et al, 2019, Cells CrossRef
8. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
   Himavanth Gatla et al, 2019, International Journal of Molecular Sciences CrossRef